The Quantellect read.As of Nov 19, 2026, 12 active firms cover Regency Centers Corporation: 5 rate it Buy or better, 7 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $76.00 to $88.00, so the covering firms are broadly aligned. The average target of $82.64 sits 10% above the current $75.19. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.65 next quarter toward $2.53 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 active firms
Neutral
Strong Buy00%
Buy542%
Neutral758%
Sell00%
Strong Sell00%
Based on 12 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$82.64
+9.9% upside
Average target across 11 active firms as of Nov 19, 2026 vs $75.19 current
Highest Target$88.00
Average Target$82.64
Lowest Target$76.00
Detailed analyst forecasts for REG
Showing 1–14 of 14 named analysts shown · 12 active firms in the rating projection
As of Nov 19, 2026, 5 of 12 active firms rate REG a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
REG EPS & revenue forecast
EPS · NEXT QUARTER
$0.65
Range $0.64 – $0.65 · 3 analysts · +0% YoY
Next period, 3 analysts expect Regency Centers Corporation to earn $0.65 a share (range $0.64 – $0.65), versus $0.64 a year earlier. Full-year consensus is $2.41, growing to $2.53 the year after.
REVENUE · NEXT QUARTER
$424.9M
Range $419.0M – $430.7M · 3 analysts · +5% YoY
Revenue is expected to reach $424.9M (range $419.0M – $430.7M), +4.8% year-over-year. Full-year consensus is $1.6B, rising to $1.7B next year.
Top analysts covering Regency Centers Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on REG.
#1
RJ Milligan
Raymond James · Rank #31
Buy
$88.00+17.0% to target
Overall win rate
55%
+ Follow
#2
Nicholas Yulico
Scotiabank · Rank #77
Neutral
$81.00+7.7% to target
Overall win rate
53%
+ Follow
#3
Steve Sakwa
Evercore ISI Group · Rank #175
Neutral
$81.00+7.7% to target
Overall win rate
40%
+ Follow
#4
Richard Hightower
Barclays · Rank #184
Buy
$85.00+13.0% to target
Overall win rate
45%
+ Follow
#5
Michael Lewis
Truist Securities · Rank #243
Buy
No targeton REG
Overall win rate
43%
+ Follow
REG stock forecast FAQ
What is REG's average 12-month price target?+
The 11 active firms with a live target average $82.64 for Regency Centers Corporation over the next 12 months, ranging from a $88.00 high to a $76.00 low, as of Nov 19, 2026.
Is REG stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 12 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 7 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for REG?+
The Street-high target is $88.00 (Wells Fargo), and the Street-low is $76.00 (Mizuho). The average of all 11 active-firm targets is $82.64.
How many active Wall Street firms cover REG?+
12 active firms have a recognized rating on Regency Centers Corporation as of Nov 19, 2026, and 11 active firms carry a live 12-month price target.
Who is the most accurate analyst covering REG?+
Among analysts who currently cover REG, RJ Milligan of Raymond James has the strongest overall Quantellect track record (Rank #31). Their current call is Buy with a $88.00 target.
What is Regency Centers Corporation's projected EPS for next quarter?+
The consensus estimate is $0.65 per share (range $0.64 – $0.65) across 3 analysts. Full-year EPS is projected at $2.41, rising to $2.53 the following year.
How much revenue is Regency Centers Corporation expected to report next quarter?+
Consensus revenue is $424.9M (range $419.0M – $430.7M). Full-year revenue is projected at $1.6B, growing to $1.7B next year.
Have analysts been upgrading or downgrading REG lately?+
As of Nov 19, 2026, 5 of 12 active firms rate REG a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their REG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.